4859 articles
New research reveals how dietary nitrate supplements modify taste perception through changes in oral microbiome and bacterial metabolites.
Sequential CDK4/6 inhibitor treatment before anti-PD-1 therapy enhances immune response and tumor control in head and neck cancer models.
New research reveals how androgen deprivation therapy disrupts gut microbiome and bile acids, causing memory problems through brain signaling pathways.
Stanford researchers develop standardized method to measure absolute bacterial abundance in stool samples, addressing key limitation in microbiome studies.
Analysis of 339,242 Americans shows higher gut microbiota dietary scores linked to lower metabolic syndrome risk through reduced inflammation.
Study shows probiotic bacteria shields heart muscle from toxic effects of cancer chemotherapy through metabolite pathway.
Flaxseed compounds enhance PD-1 inhibitor effectiveness against breast cancer through gut bacteria modulation and immune system activation.
Study of 270 patients reveals specific gut microbes linked to better survival and fewer severe side effects from immunotherapy.
New review reveals how shared aging mechanisms drive multiple diseases, opening doors to therapies that extend healthspan rather than treat single conditions.
Large US study reveals epigenetic aging markers, especially GrimAge, predict death better than telomere length across racial groups.
Dutch twin study reveals blood-based epigenetic age acceleration correlates with brain MRI aging, driven by environmental factors.
Study of 2,939 childhood cancer survivors reveals how accelerated aging explains up to 35% of treatment-related heart disease risk.
